Industry Research Reports
Home > Reports > Medical Devices & Consumables > Global Recombinant Human Neuregulin Kit Market Research Report 2024
Global Recombinant Human Neuregulin Kit Market Research Report 2024
Industry: Medical Devices & Consumables
Published Date: 2024-12-06
Pages: 96 Pages
Report ld: 3394972
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Recombinant Human Neuregulin Kit Market Size(US$)
CAGR 2024-2030
5%
Market Size,2030
USD 296
Million
Market Snapshot
Market Size in 2024 (Value)
US$ 221 million
Market Forecast in 2030(Value)
US$ 296 million
CAGR
5%
Years Considered
2019-2030
Base Year
2024
Forecast Period
2024-2030
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for Recombinant Human Neuregulin Kit was valued at US$ 208 million in the year 2023 and is projected to reach a revised size of US$ 296 million by 2030, growing at a CAGR of 5.0% during the forecast period.
Recombinant human neuregulin is a class of EGF-like signaling molecules, which are a class of paracrine, autocrine and paracrine signaling polypeptides that mediate a variety of cellular functions in neurons and non-neural systems, including survival, proliferation and differentiation. NRGs participate in cell-cell crosstalk and play an important role in the development, maintenance and repair of organs such as the nervous system, heart and breast.
North American market for Recombinant Human Neuregulin Kit is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Recombinant Human Neuregulin Kit is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Recombinant Human Neuregulin Kit include BPS Bioscience, R&D Systems, Inc., YEASEN, Sinobiological, InVitria, Thermo Fisher Scientific Inc., Cell Guidance Systems LLC, Abcam Limited, ACROBiosystems, Proteintech Group, Inc, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
REPORT SCOPE
This report aims to provide a comprehensive presentation of the global market for Recombinant Human Neuregulin Kit, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Recombinant Human Neuregulin Kit.
The Recombinant Human Neuregulin Kit market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Recombinant Human Neuregulin Kit market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Recombinant Human Neuregulin Kit manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
BPS Bioscience
R&D Systems, Inc.
YEASEN
Sinobiological
InVitria
Thermo Fisher Scientific Inc.
Cell Guidance Systems LLC
Abcam Limited
ACROBiosystems
Proteintech Group, Inc
BioLegend, Inc
Segment by Type
Purity < 97%
Purity ≥ 97%
Segment by Application
Laboratory
University
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Recombinant Human Neuregulin Kit manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Recombinant Human Neuregulin Kit in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Recombinant Human Neuregulin Kit Market Overview
1.1 Product Definition
1.2 Recombinant Human Neuregulin Kit by Type
1.2.1 Global Recombinant Human Neuregulin Kit Market Value Comparison by Type (2024-2030)
1.2.2 Purity < 97%
1.2.3 Purity ≥ 97%
1.3 Recombinant Human Neuregulin Kit by Application
1.3.1 Global Recombinant Human Neuregulin Kit Market Value by Application (2024-2030)
1.3.2 Laboratory
1.3.3 University
1.3.4 Others
1.4 Global Recombinant Human Neuregulin Kit Market Size Estimates and Forecasts
1.4.1 Global Recombinant Human Neuregulin Kit Revenue 2019-2030
1.4.2 Global Recombinant Human Neuregulin Kit Sales 2019-2030
1.4.3 Global Recombinant Human Neuregulin Kit Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Recombinant Human Neuregulin Kit Market Competition by Manufacturers
2.1 Global Recombinant Human Neuregulin Kit Sales Market Share by Manufacturers (2019-2024)
2.2 Global Recombinant Human Neuregulin Kit Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Recombinant Human Neuregulin Kit Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Recombinant Human Neuregulin Kit, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Recombinant Human Neuregulin Kit, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Recombinant Human Neuregulin Kit, Product Type & Application
2.7 Global Key Manufacturers of Recombinant Human Neuregulin Kit, Date of Enter into This Industry
2.8 Global Recombinant Human Neuregulin Kit Market Competitive Situation and Trends
2.8.1 Global Recombinant Human Neuregulin Kit Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Recombinant Human Neuregulin Kit Players Market Share by Revenue
2.8.3 Global Recombinant Human Neuregulin Kit Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Recombinant Human Neuregulin Kit Market Scenario by Region
3.1 Global Recombinant Human Neuregulin Kit Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Recombinant Human Neuregulin Kit Sales by Region: 2019-2030
3.2.1 Global Recombinant Human Neuregulin Kit Sales by Region: 2019-2024
3.2.2 Global Recombinant Human Neuregulin Kit Sales by Region: 2025-2030
3.3 Global Recombinant Human Neuregulin Kit Revenue by Region: 2019-2030
3.3.1 Global Recombinant Human Neuregulin Kit Revenue by Region: 2019-2024
3.3.2 Global Recombinant Human Neuregulin Kit Revenue by Region: 2025-2030
3.4 North America Recombinant Human Neuregulin Kit Market Facts & Figures by Country
3.4.1 North America Recombinant Human Neuregulin Kit Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Recombinant Human Neuregulin Kit Sales by Country (2019-2030)
3.4.3 North America Recombinant Human Neuregulin Kit Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Recombinant Human Neuregulin Kit Market Facts & Figures by Country
3.5.1 Europe Recombinant Human Neuregulin Kit Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Recombinant Human Neuregulin Kit Sales by Country (2019-2030)
3.5.3 Europe Recombinant Human Neuregulin Kit Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Recombinant Human Neuregulin Kit Market Facts & Figures by Region
3.6.1 Asia Pacific Recombinant Human Neuregulin Kit Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Recombinant Human Neuregulin Kit Sales by Region (2019-2030)
3.6.3 Asia Pacific Recombinant Human Neuregulin Kit Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Recombinant Human Neuregulin Kit Market Facts & Figures by Country
3.7.1 Latin America Recombinant Human Neuregulin Kit Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Recombinant Human Neuregulin Kit Sales by Country (2019-2030)
3.7.3 Latin America Recombinant Human Neuregulin Kit Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Recombinant Human Neuregulin Kit Market Facts & Figures by Country
3.8.1 Middle East and Africa Recombinant Human Neuregulin Kit Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Recombinant Human Neuregulin Kit Sales by Country (2019-2030)
3.8.3 Middle East and Africa Recombinant Human Neuregulin Kit Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Recombinant Human Neuregulin Kit Sales by Type (2019-2030)
4.1.1 Global Recombinant Human Neuregulin Kit Sales by Type (2019-2024)
4.1.2 Global Recombinant Human Neuregulin Kit Sales by Type (2025-2030)
4.1.3 Global Recombinant Human Neuregulin Kit Sales Market Share by Type (2019-2030)
4.2 Global Recombinant Human Neuregulin Kit Revenue by Type (2019-2030)
4.2.1 Global Recombinant Human Neuregulin Kit Revenue by Type (2019-2024)
4.2.2 Global Recombinant Human Neuregulin Kit Revenue by Type (2025-2030)
4.2.3 Global Recombinant Human Neuregulin Kit Revenue Market Share by Type (2019-2030)
4.3 Global Recombinant Human Neuregulin Kit Price by Type (2019-2030)
5 Segment by Application
5.1 Global Recombinant Human Neuregulin Kit Sales by Application (2019-2030)
5.1.1 Global Recombinant Human Neuregulin Kit Sales by Application (2019-2024)
5.1.2 Global Recombinant Human Neuregulin Kit Sales by Application (2025-2030)
5.1.3 Global Recombinant Human Neuregulin Kit Sales Market Share by Application (2019-2030)
5.2 Global Recombinant Human Neuregulin Kit Revenue by Application (2019-2030)
5.2.1 Global Recombinant Human Neuregulin Kit Revenue by Application (2019-2024)
5.2.2 Global Recombinant Human Neuregulin Kit Revenue by Application (2025-2030)
5.2.3 Global Recombinant Human Neuregulin Kit Revenue Market Share by Application (2019-2030)
5.3 Global Recombinant Human Neuregulin Kit Price by Application (2019-2030)
6 Key Companies Profiled
6.1 BPS Bioscience
6.1.1 BPS Bioscience Company Information
6.1.2 BPS Bioscience Description and Business Overview
6.1.3 BPS Bioscience Recombinant Human Neuregulin Kit Sales, Revenue and Gross Margin (2019-2024)
6.1.4 BPS Bioscience Recombinant Human Neuregulin Kit Product Portfolio
6.1.5 BPS Bioscience Recent Developments/Updates
6.2 R&D Systems, Inc.
6.2.1 R&D Systems, Inc. Company Information
6.2.2 R&D Systems, Inc. Description and Business Overview
6.2.3 R&D Systems, Inc. Recombinant Human Neuregulin Kit Sales, Revenue and Gross Margin (2019-2024)
6.2.4 R&D Systems, Inc. Recombinant Human Neuregulin Kit Product Portfolio
6.2.5 R&D Systems, Inc. Recent Developments/Updates
6.3 YEASEN
6.3.1 YEASEN Company Information
6.3.2 YEASEN Description and Business Overview
6.3.3 YEASEN Recombinant Human Neuregulin Kit Sales, Revenue and Gross Margin (2019-2024)
6.3.4 YEASEN Recombinant Human Neuregulin Kit Product Portfolio
6.3.5 YEASEN Recent Developments/Updates
6.4 Sinobiological
6.4.1 Sinobiological Company Information
6.4.2 Sinobiological Description and Business Overview
6.4.3 Sinobiological Recombinant Human Neuregulin Kit Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Sinobiological Recombinant Human Neuregulin Kit Product Portfolio
6.4.5 Sinobiological Recent Developments/Updates
6.5 InVitria
6.5.1 InVitria Company Information
6.5.2 InVitria Description and Business Overview
6.5.3 InVitria Recombinant Human Neuregulin Kit Sales, Revenue and Gross Margin (2019-2024)
6.5.4 InVitria Recombinant Human Neuregulin Kit Product Portfolio
6.5.5 InVitria Recent Developments/Updates
6.6 Thermo Fisher Scientific Inc.
6.6.1 Thermo Fisher Scientific Inc. Company Information
6.6.2 Thermo Fisher Scientific Inc. Description and Business Overview
6.6.3 Thermo Fisher Scientific Inc. Recombinant Human Neuregulin Kit Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Thermo Fisher Scientific Inc. Recombinant Human Neuregulin Kit Product Portfolio
6.6.5 Thermo Fisher Scientific Inc. Recent Developments/Updates
6.7 Cell Guidance Systems LLC
6.7.1 Cell Guidance Systems LLC Company Information
6.7.2 Cell Guidance Systems LLC Description and Business Overview
6.7.3 Cell Guidance Systems LLC Recombinant Human Neuregulin Kit Sales, Revenue and Gross Margin (2019-2024)
6.7.4 Cell Guidance Systems LLC Recombinant Human Neuregulin Kit Product Portfolio
6.7.5 Cell Guidance Systems LLC Recent Developments/Updates
6.8 Abcam Limited
6.8.1 Abcam Limited Company Information
6.8.2 Abcam Limited Description and Business Overview
6.8.3 Abcam Limited Recombinant Human Neuregulin Kit Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Abcam Limited Recombinant Human Neuregulin Kit Product Portfolio
6.8.5 Abcam Limited Recent Developments/Updates
6.9 ACROBiosystems
6.9.1 ACROBiosystems Company Information
6.9.2 ACROBiosystems Description and Business Overview
6.9.3 ACROBiosystems Recombinant Human Neuregulin Kit Sales, Revenue and Gross Margin (2019-2024)
6.9.4 ACROBiosystems Recombinant Human Neuregulin Kit Product Portfolio
6.9.5 ACROBiosystems Recent Developments/Updates
6.10 Proteintech Group, Inc
6.10.1 Proteintech Group, Inc Company Information
6.10.2 Proteintech Group, Inc Description and Business Overview
6.10.3 Proteintech Group, Inc Recombinant Human Neuregulin Kit Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Proteintech Group, Inc Recombinant Human Neuregulin Kit Product Portfolio
6.10.5 Proteintech Group, Inc Recent Developments/Updates
6.11 BioLegend, Inc
6.11.1 BioLegend, Inc Company Information
6.11.2 BioLegend, Inc Description and Business Overview
6.11.3 BioLegend, Inc Recombinant Human Neuregulin Kit Sales, Revenue and Gross Margin (2019-2024)
6.11.4 BioLegend, Inc Recombinant Human Neuregulin Kit Product Portfolio
6.11.5 BioLegend, Inc Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Recombinant Human Neuregulin Kit Industry Chain Analysis
7.2 Recombinant Human Neuregulin Kit Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Recombinant Human Neuregulin Kit Production Mode & Process
7.4 Recombinant Human Neuregulin Kit Sales and Marketing
7.4.1 Recombinant Human Neuregulin Kit Sales Channels
7.4.2 Recombinant Human Neuregulin Kit Distributors
7.5 Recombinant Human Neuregulin Kit Customers
8 Recombinant Human Neuregulin Kit Market Dynamics
8.1 Recombinant Human Neuregulin Kit Industry Trends
8.2 Recombinant Human Neuregulin Kit Market Drivers
8.3 Recombinant Human Neuregulin Kit Market Challenges
8.4 Recombinant Human Neuregulin Kit Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. Global Recombinant Human Neuregulin Kit Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Recombinant Human Neuregulin Kit Market Value by Application (2024-2030) & (US$ Million)
Table 3. Global Recombinant Human Neuregulin Kit Market Competitive Situation by Manufacturers in 2023
Table 4. Global Recombinant Human Neuregulin Kit Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Recombinant Human Neuregulin Kit Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Recombinant Human Neuregulin Kit Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Recombinant Human Neuregulin Kit Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Recombinant Human Neuregulin Kit Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Recombinant Human Neuregulin Kit, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Recombinant Human Neuregulin Kit, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Recombinant Human Neuregulin Kit, Product Type & Application
Table 12. Global Key Manufacturers of Recombinant Human Neuregulin Kit, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Recombinant Human Neuregulin Kit by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant Human Neuregulin Kit as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Recombinant Human Neuregulin Kit Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Recombinant Human Neuregulin Kit Sales by Region (2019-2024) & (K Units)
Table 18. Global Recombinant Human Neuregulin Kit Sales Market Share by Region (2019-2024)
Table 19. Global Recombinant Human Neuregulin Kit Sales by Region (2025-2030) & (K Units)
Table 20. Global Recombinant Human Neuregulin Kit Sales Market Share by Region (2025-2030)
Table 21. Global Recombinant Human Neuregulin Kit Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Recombinant Human Neuregulin Kit Revenue Market Share by Region (2019-2024)
Table 23. Global Recombinant Human Neuregulin Kit Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Recombinant Human Neuregulin Kit Revenue Market Share by Region (2025-2030)
Table 25. North America Recombinant Human Neuregulin Kit Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Recombinant Human Neuregulin Kit Sales by Country (2019-2024) & (K Units)
Table 27. North America Recombinant Human Neuregulin Kit Sales by Country (2025-2030) & (K Units)
Table 28. North America Recombinant Human Neuregulin Kit Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Recombinant Human Neuregulin Kit Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Recombinant Human Neuregulin Kit Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Recombinant Human Neuregulin Kit Sales by Country (2019-2024) & (K Units)
Table 32. Europe Recombinant Human Neuregulin Kit Sales by Country (2025-2030) & (K Units)
Table 33. Europe Recombinant Human Neuregulin Kit Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Recombinant Human Neuregulin Kit Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Recombinant Human Neuregulin Kit Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Recombinant Human Neuregulin Kit Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Recombinant Human Neuregulin Kit Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Recombinant Human Neuregulin Kit Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Recombinant Human Neuregulin Kit Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Recombinant Human Neuregulin Kit Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Recombinant Human Neuregulin Kit Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Recombinant Human Neuregulin Kit Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Recombinant Human Neuregulin Kit Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Recombinant Human Neuregulin Kit Revenue Market Share by Country (2019-2024)
Table 45. Middle East and Africa Recombinant Human Neuregulin Kit Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East and Africa Recombinant Human Neuregulin Kit Sales by Country (2019-2024) & (K Units)
Table 47. Middle East and Africa Recombinant Human Neuregulin Kit Sales by Country (2025-2030) & (K Units)
Table 48. Middle East and Africa Recombinant Human Neuregulin Kit Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East and Africa Recombinant Human Neuregulin Kit Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Recombinant Human Neuregulin Kit Sales (K Units) by Type (2019-2024)
Table 51. Global Recombinant Human Neuregulin Kit Sales (K Units) by Type (2025-2030)
Table 52. Global Recombinant Human Neuregulin Kit Sales Market Share by Type (2019-2024)
Table 53. Global Recombinant Human Neuregulin Kit Sales Market Share by Type (2025-2030)
Table 54. Global Recombinant Human Neuregulin Kit Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Recombinant Human Neuregulin Kit Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Recombinant Human Neuregulin Kit Revenue Market Share by Type (2019-2024)
Table 57. Global Recombinant Human Neuregulin Kit Revenue Market Share by Type (2025-2030)
Table 58. Global Recombinant Human Neuregulin Kit Price (US$/Unit) by Type (2019-2024)
Table 59. Global Recombinant Human Neuregulin Kit Price (US$/Unit) by Type (2025-2030)
Table 60. Global Recombinant Human Neuregulin Kit Sales (K Units) by Application (2019-2024)
Table 61. Global Recombinant Human Neuregulin Kit Sales (K Units) by Application (2025-2030)
Table 62. Global Recombinant Human Neuregulin Kit Sales Market Share by Application (2019-2024)
Table 63. Global Recombinant Human Neuregulin Kit Sales Market Share by Application (2025-2030)
Table 64. Global Recombinant Human Neuregulin Kit Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Recombinant Human Neuregulin Kit Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Recombinant Human Neuregulin Kit Revenue Market Share by Application (2019-2024)
Table 67. Global Recombinant Human Neuregulin Kit Revenue Market Share by Application (2025-2030)
Table 68. Global Recombinant Human Neuregulin Kit Price (US$/Unit) by Application (2019-2024)
Table 69. Global Recombinant Human Neuregulin Kit Price (US$/Unit) by Application (2025-2030)
Table 70. BPS Bioscience Company Information
Table 71. BPS Bioscience Description and Business Overview
Table 72. BPS Bioscience Recombinant Human Neuregulin Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. BPS Bioscience Recombinant Human Neuregulin Kit Product
Table 74. BPS Bioscience Recent Developments/Updates
Table 75. R&D Systems, Inc. Company Information
Table 76. R&D Systems, Inc. Description and Business Overview
Table 77. R&D Systems, Inc. Recombinant Human Neuregulin Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. R&D Systems, Inc. Recombinant Human Neuregulin Kit Product
Table 79. R&D Systems, Inc. Recent Developments/Updates
Table 80. YEASEN Company Information
Table 81. YEASEN Description and Business Overview
Table 82. YEASEN Recombinant Human Neuregulin Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. YEASEN Recombinant Human Neuregulin Kit Product
Table 84. YEASEN Recent Developments/Updates
Table 85. Sinobiological Company Information
Table 86. Sinobiological Description and Business Overview
Table 87. Sinobiological Recombinant Human Neuregulin Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Sinobiological Recombinant Human Neuregulin Kit Product
Table 89. Sinobiological Recent Developments/Updates
Table 90. InVitria Company Information
Table 91. InVitria Description and Business Overview
Table 92. InVitria Recombinant Human Neuregulin Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. InVitria Recombinant Human Neuregulin Kit Product
Table 94. InVitria Recent Developments/Updates
Table 95. Thermo Fisher Scientific Inc. Company Information
Table 96. Thermo Fisher Scientific Inc. Description and Business Overview
Table 97. Thermo Fisher Scientific Inc. Recombinant Human Neuregulin Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Thermo Fisher Scientific Inc. Recombinant Human Neuregulin Kit Product
Table 99. Thermo Fisher Scientific Inc. Recent Developments/Updates
Table 100. Cell Guidance Systems LLC Company Information
Table 101. Cell Guidance Systems LLC Description and Business Overview
Table 102. Cell Guidance Systems LLC Recombinant Human Neuregulin Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Cell Guidance Systems LLC Recombinant Human Neuregulin Kit Product
Table 104. Cell Guidance Systems LLC Recent Developments/Updates
Table 105. Abcam Limited Company Information
Table 106. Abcam Limited Description and Business Overview
Table 107. Abcam Limited Recombinant Human Neuregulin Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. Abcam Limited Recombinant Human Neuregulin Kit Product
Table 109. Abcam Limited Recent Developments/Updates
Table 110. ACROBiosystems Company Information
Table 111. ACROBiosystems Description and Business Overview
Table 112. ACROBiosystems Recombinant Human Neuregulin Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. ACROBiosystems Recombinant Human Neuregulin Kit Product
Table 114. ACROBiosystems Recent Developments/Updates
Table 115. Proteintech Group, Inc Company Information
Table 116. Proteintech Group, Inc Description and Business Overview
Table 117. Proteintech Group, Inc Recombinant Human Neuregulin Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. Proteintech Group, Inc Recombinant Human Neuregulin Kit Product
Table 119. Proteintech Group, Inc Recent Developments/Updates
Table 120. BioLegend, Inc Company Information
Table 121. BioLegend, Inc Description and Business Overview
Table 122. BioLegend, Inc Recombinant Human Neuregulin Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 123. BioLegend, Inc Recombinant Human Neuregulin Kit Product
Table 124. BioLegend, Inc Recent Developments/Updates
Table 125. Key Raw Materials Lists
Table 126. Raw Materials Key Suppliers Lists
Table 127. Recombinant Human Neuregulin Kit Distributors List
Table 128. Recombinant Human Neuregulin Kit Customers List
Table 129. Recombinant Human Neuregulin Kit Market Trends
Table 130. Recombinant Human Neuregulin Kit Market Drivers
Table 131. Recombinant Human Neuregulin Kit Market Challenges
Table 132. Recombinant Human Neuregulin Kit Market Restraints
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
Table 136. Authors List of This Report
List of Figures
Figure 1. Product Picture of Recombinant Human Neuregulin Kit
Figure 2. Global Recombinant Human Neuregulin Kit Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Recombinant Human Neuregulin Kit Market Share by Type: 2023 & 2030
Figure 4. Purity < 97% Product Picture
Figure 5. Purity ≥ 97% Product Picture
Figure 6. Global Recombinant Human Neuregulin Kit Market Value by Application (2024-2030) & (US$ Million)
Figure 7. Global Recombinant Human Neuregulin Kit Market Share by Application: 2023 & 2030
Figure 8. Laboratory
Figure 9. University
Figure 10. Others
Figure 11. Global Recombinant Human Neuregulin Kit Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Recombinant Human Neuregulin Kit Market Size (2019-2030) & (US$ Million)
Figure 13. Global Recombinant Human Neuregulin Kit Sales (2019-2030) & (K Units)
Figure 14. Global Recombinant Human Neuregulin Kit Average Price (US$/Unit) & (2019-2030)
Figure 15. Recombinant Human Neuregulin Kit Report Years Considered
Figure 16. Recombinant Human Neuregulin Kit Sales Share by Manufacturers in 2023
Figure 17. Global Recombinant Human Neuregulin Kit Revenue Share by Manufacturers in 2023
Figure 18. Global 5 and 10 Largest Recombinant Human Neuregulin Kit Players: Market Share by Revenue in Recombinant Human Neuregulin Kit in 2023
Figure 19. Recombinant Human Neuregulin Kit Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 20. Global Recombinant Human Neuregulin Kit Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 21. North America Recombinant Human Neuregulin Kit Sales Market Share by Country (2019-2030)
Figure 22. North America Recombinant Human Neuregulin Kit Revenue Market Share by Country (2019-2030)
Figure 23. United States Recombinant Human Neuregulin Kit Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Canada Recombinant Human Neuregulin Kit Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Europe Recombinant Human Neuregulin Kit Sales Market Share by Country (2019-2030)
Figure 26. Europe Recombinant Human Neuregulin Kit Revenue Market Share by Country (2019-2030)
Figure 27. Germany Recombinant Human Neuregulin Kit Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. France Recombinant Human Neuregulin Kit Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. U.K. Recombinant Human Neuregulin Kit Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Italy Recombinant Human Neuregulin Kit Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Russia Recombinant Human Neuregulin Kit Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Asia Pacific Recombinant Human Neuregulin Kit Sales Market Share by Region (2019-2030)
Figure 33. Asia Pacific Recombinant Human Neuregulin Kit Revenue Market Share by Region (2019-2030)
Figure 34. China Recombinant Human Neuregulin Kit Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Japan Recombinant Human Neuregulin Kit Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. South Korea Recombinant Human Neuregulin Kit Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. India Recombinant Human Neuregulin Kit Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Australia Recombinant Human Neuregulin Kit Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. China Taiwan Recombinant Human Neuregulin Kit Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Southeast Asia Recombinant Human Neuregulin Kit Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Latin America Recombinant Human Neuregulin Kit Sales Market Share by Country (2019-2030)
Figure 42. Mexico Recombinant Human Neuregulin Kit Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Brazil Recombinant Human Neuregulin Kit Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Argentina Recombinant Human Neuregulin Kit Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Colombia Recombinant Human Neuregulin Kit Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Middle East and Africa Recombinant Human Neuregulin Kit Sales Market Share by Country (2019-2030)
Figure 47. Middle East and Africa Recombinant Human Neuregulin Kit Revenue Market Share by Country (2019-2030)
Figure 48. Turkey Recombinant Human Neuregulin Kit Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Saudi Arabia Recombinant Human Neuregulin Kit Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. UAE Recombinant Human Neuregulin Kit Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Global Sales Market Share of Recombinant Human Neuregulin Kit by Type (2019-2030)
Figure 52. Global Revenue Market Share of Recombinant Human Neuregulin Kit by Type (2019-2030)
Figure 53. Global Recombinant Human Neuregulin Kit Price (US$/Unit) by Type (2019-2030)
Figure 54. Global Sales Market Share of Recombinant Human Neuregulin Kit by Application (2019-2030)
Figure 55. Global Revenue Market Share of Recombinant Human Neuregulin Kit by Application (2019-2030)
Figure 56. Global Recombinant Human Neuregulin Kit Price (US$/Unit) by Application (2019-2030)
Figure 57. Recombinant Human Neuregulin Kit Value Chain
Figure 58. Recombinant Human Neuregulin Kit Production Process
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
What was the global market size of Recombinant Human Neuregulin Kit in 2030?
The global market size of Recombinant Human Neuregulin Kit in 2030 was 296 Million USD.
Which region is expected to have the highest market share?
What was the global market size of Recombinant Human Neuregulin Kit in 2024?
Which companies rank high in the global Recombinant Human Neuregulin Kit market?
What is the annual compound growth rate of the global Recombinant Human Neuregulin Kit market size from 2024 to 2030?
Related Reports
Global Recombinant Human Neuregulin Kit Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Recombinant Human Neuregulin Kit market is projected to grow from US$ 231 million in 2025 to US$ 323 million by 2032, at a CAGR of 5.0% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-25
Pages: 169
USD 4900.00
(Single User License)
Global Recombinant Human Neuregulin Kit Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Recombinant Human Neuregulin Kit market size was US$ 231 million in 2025 and is forecast to reach a readjusted size of US$ 323 million by 2032 with a CAGR of 5.0% during the forecast period 2026-2032.
Published Date: 2026-03-25
Pages: 93
USD 4250.00
(Single User License)
Global Recombinant Human Neuregulin Kit Market Research Report 2026
The global Recombinant Human Neuregulin Kit market was valued at US$ 231 million in 2025 and is anticipated to reach US$ 323 million by 2032, at a CAGR of 5.0% from 2026 to 2032.
Published Date: 2026-01-08
Pages: 126
USD 2900.00
(Single User License)
Recombinant Human Neuregulin Kit- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Recombinant Human Neuregulin Kit was estimated to be worth US$ 231 million in 2025 and is projected to reach US$ 323 million, growing at a CAGR of 5.0% from 2026 to 2032.
Published Date: 2026-01-08
Pages: 128
USD 3950.00
(Single User License)
Global Recombinant Human Neuregulin Kit Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Recombinant Human Neuregulin Kit market size was US$ 221 million in 2024 and is forecast to a readjusted size of US$ 309 million by 2031 with a CAGR of 5.0% during the forecast period 2025-2031.
Published Date: 2025-08-01
Pages: 93
USD 4250.00
(Single User License)
Global Recombinant Human Neuregulin Kit Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Recombinant Human Neuregulin Kit market is projected to grow from US$ 221 million in 2024 to US$ 309 million by 2031, at a CAGR of 5.0% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-08-01
Pages: 159
USD 4900.00
(Single User License)
Recombinant Human Neuregulin Kit - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Recombinant Human Neuregulin Kit was estimated to be worth US$ 221 million in 2024 and is forecast to a readjusted size of US$ 309 million by 2031 with a CAGR of 5.0% during the forecast period 2025-2031.
Published Date: 2025-03-10
Pages: 121
USD 3950.00
(Single User License)
Global Recombinant Human Neuregulin Kit Market Research Report 2025
The global market for Recombinant Human Neuregulin Kit was valued at US$ 221 million in the year 2024 and is projected to reach a revised size of US$ 309 million by 2031, growing at a CAGR of 5.0% during the forecast period.
Published Date: 2025-03-10
Pages: 92
USD 2900.00
(Single User License)
Recombinant Human Neuregulin Kit- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for Recombinant Human Neuregulin Kit was estimated to be worth US$ 208 million in 2023 and is forecast to a readjusted size of US$ 296 million by 2030 with a CAGR of 5.0% during the forecast period 2024-2030.
Published Date: 2024-12-06
Pages: 126
USD 3950.00
(Single User License)
Global and United States Recombinant Human Neuregulin Kit Market Report & Forecast 2024-2030
The global Recombinant Human Neuregulin Kit revenue was US$ 208 million in 2023 and is forecast to a readjusted size of US$ 296 million by 2030 with a CAGR of 5.0% during the review period (2024-2030).
Published Date: 2024-12-06
Pages: 129
USD 4350.00
(Single User License)
Global Recombinant Human Neuregulin Kit Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Recombinant Human Neuregulin Kit market is projected to grow from US$ 231 million in 2025 to US$ 323 million by 2032, at a CAGR of 5.0% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-25
Pages: 169
USD 4900.00 (Single User License)Global Recombinant Human Neuregulin Kit Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Recombinant Human Neuregulin Kit market size was US$ 231 million in 2025 and is forecast to reach a readjusted size of US$ 323 million by 2032 with a CAGR of 5.0% during the forecast period 2026-2032.
Published: 2026-03-25
Pages: 93
USD 4250.00 (Single User License)Global Recombinant Human Neuregulin Kit Market Research Report 2026
The global Recombinant Human Neuregulin Kit market was valued at US$ 231 million in 2025 and is anticipated to reach US$ 323 million by 2032, at a CAGR of 5.0% from 2026 to 2032.
Published: 2026-01-08
Pages: 126
USD 2900.00 (Single User License)Recombinant Human Neuregulin Kit- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Recombinant Human Neuregulin Kit was estimated to be worth US$ 231 million in 2025 and is projected to reach US$ 323 million, growing at a CAGR of 5.0% from 2026 to 2032.
Published: 2026-01-08
Pages: 128
USD 3950.00 (Single User License)Global Recombinant Human Neuregulin Kit Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Recombinant Human Neuregulin Kit market size was US$ 221 million in 2024 and is forecast to a readjusted size of US$ 309 million by 2031 with a CAGR of 5.0% during the forecast period 2025-2031.
Published: 2025-08-01
Pages: 93
USD 4250.00 (Single User License)Global Recombinant Human Neuregulin Kit Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Recombinant Human Neuregulin Kit market is projected to grow from US$ 221 million in 2024 to US$ 309 million by 2031, at a CAGR of 5.0% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-08-01
Pages: 159
USD 4900.00 (Single User License)Recombinant Human Neuregulin Kit - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Recombinant Human Neuregulin Kit was estimated to be worth US$ 221 million in 2024 and is forecast to a readjusted size of US$ 309 million by 2031 with a CAGR of 5.0% during the forecast period 2025-2031.
Published: 2025-03-10
Pages: 121
USD 3950.00 (Single User License)Global Recombinant Human Neuregulin Kit Market Research Report 2025
The global market for Recombinant Human Neuregulin Kit was valued at US$ 221 million in the year 2024 and is projected to reach a revised size of US$ 309 million by 2031, growing at a CAGR of 5.0% during the forecast period.
Published: 2025-03-10
Pages: 92
USD 2900.00 (Single User License)Recombinant Human Neuregulin Kit- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for Recombinant Human Neuregulin Kit was estimated to be worth US$ 208 million in 2023 and is forecast to a readjusted size of US$ 296 million by 2030 with a CAGR of 5.0% during the forecast period 2024-2030.
Published: 2024-12-06
Pages: 126
USD 3950.00 (Single User License)Global and United States Recombinant Human Neuregulin Kit Market Report & Forecast 2024-2030
The global Recombinant Human Neuregulin Kit revenue was US$ 208 million in 2023 and is forecast to a readjusted size of US$ 296 million by 2030 with a CAGR of 5.0% during the review period (2024-2030).
Published: 2024-12-06
Pages: 129
USD 4350.00 (Single User License)
CHOOSE LICENSE TYPE
USD 2900.00
USD 4350.00
USD 5800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
REPORT SCOPE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now